Public Consultation: Draft 2026-27 Cost Recovery Implementation Statement (CRIS) for listing medicines on the PBS and designated vaccines on the NIP

Page last updated: 30 April 2026

Consultation on the draft 2026-27 Cost Recovery Implementation Statement (CRIS) for listing medicines on the Pharmaceutical Benefits Scheme and designated vaccines on the National Immunisation Program is now open.

This CRIS sets out the fees that will apply for the 2026-27 financial year and provides information on how the Department of Health, Disability and Ageing (the Department) implements cost recovery for:

• submissions to the Pharmaceutical Benefits Advisory Committee (PBAC) for medicines seeking to be listed on the Pharmaceutical Benefits Scheme (PBS); or vaccines to be listed on the National Immunisation Program (NIP)
•  applicant-driven PBS listing and list management activities. 

For the 2026-27 financial year there will be no change to fees from the 2025-26 rates.

The final CRIS will be published and take effect on 1 July 2026.

The Department welcomes your feedback.

Please provide your comments on the content of the draft 2026-27 CRIS via email: PBScostrecovery@health.gov.au. Consultation closes COB Friday 12 June 2026.